AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
2
The man who helped build Palo Alto’s Cortex is leaving the company
3
Serbia opens Israeli drone factory as defense ties with Elbit deepen
4
“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B
5
Five months old, Noetive raises $41 million Seed to build AI for the physical economy
More news

Pharma

20 stories about Pharma
טיילורמד TailorMed מייסדי טיילור מד אדם סיטון ו שרוליק דבורסקי

TailorMed collaborates with AllianceRx Walgreens Prime to reduce patient costs

15.07.21|CTech
The Israeli company will help one of the U.S.’s largest specialty and home delivery pharmacies to quickly identify financial assistance programs for patients at risk of not affording specialty medications
קור שולץ מנכ"ל חברת טבע תרופות 23.8.20

What’s behind the timed resurgence of lawsuits against Teva?

28.08.20|Sophie Shulman
The Israeli pharmaceutical giant was hit with three legal blows over the course of a few days
קאר שולץ מנכל טבע

Teva neck-deep in legal trouble with no end in sight

20.08.20|Sophie Shulman
Each new court case is revealing that the company walked the grey line on its path to remarkable success
קור שולץ קאר שולץ מנכ"ל טבע מסיבת עיתונאים בורסה לניירות ערך

Teva stock plummets by double figures on back of U.S. government kickback lawsuit

18.08.20|CTech and Sophie Shulman
The Department of Justice accuses Israeli drugmaker of using kickbacks to boost sales of its multiple sclerosis drug Copaxone, as well as causing the submission of false claims to Medicare
מימין ניר אברהם איריס בינקוביץ' רון מירון Innocan

Israeli cannabis company InnoCan raises $3.7 million

11.06.20|CTech
InnoCan focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”) with other pharmaceutical ingredients
מפעל טבע נתניה

Israeli court documents reveal worrying details on Teva’s decision to acquire Mexico’s Rimsa

08.06.20|Sophie Shulman
Classified documents show that Teva's board of directors didn't even dedicate a full meeting to the acquisition
default image

Phage Therapies Company BiomX Raises $32 Million

20.02.19|Amarelle Wenkert
BiomX develops customized therapies based on bacteriophages—viruses that invade bacterial cells and can be used to treat infections
קאר שולץ מנכל טבע

Teva Falls in Pre-Market Following Low-Profit Forecasts for 2019

13.02.19|Lilach Baumer
The drugmaker forecasts revenues of $17 billion to 17.4 billion for 2019, much lower than analyst expectations
חממה של BOL קנאביס

Israeli Parliament Greenlights Cannabis Export, Pending Government Approval

26.12.18|Tzally Greenberg
The reform, meant to allow the export of medical cannabis farmed and processed in Israel, passed in the Israeli Parliament Tuesday
חקר DNA מעבדה

Lonza Opens Israeli Innovation Center

20.11.18|Lilach Baumer
The company announced plans for the center in 2017, stating it is looking to tap Israel's tech talent
קאר שולץ מנכל טבע

Teva Investors Are Back on the Rollercoaster

27.09.18|Lilach Baumer
The stock of Teva Pharmaceutical Industries Ltd. fell over 11% on NYSE between September 20 and Thursday, bringing a halt to a nearly two weeks rally
קאר שולץ מנכל טבע

Teva Shares Rise Following FDA Approval of Migraine Drug

16.09.18|Dror Reich
Teva’s new migraine drug is forecasted to bring in $500 million in sales annually
תרופות כדורים

Gastro Treatment Company RedHill Jumps on Nasdaq Following Successful Clinical Trial

30.07.18|Lilach Baumer
The Tel Aviv-headquartered company stated its Crohn's disease treatment trial met its primary endpoint and key secondary endpoints
נאסד"ק וול סטריט

Gastro Treatment Company RedHill Wants to Raise $117 on Nasdaq

24.07.18|Lilach Baumer
The Tel Aviv-headquartered company announced on Monday that Nasdaq approved its listing on its second tier, the Global Market. RedHill's ADSs were previously listed on Nasdaq Capital Market
default image

United Therapeutics to Acquire Pharma Company SteadyMed in a $216 Deal

30.04.18|Amarelle Wenkert
In 2017, Israeli-founded SteadyMed won a patent war against United Therapeutics
default image

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman
Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April
מעבדה לגידול קנביס רפואי מריחואנה

Israeli Cannabis Device Developer Kanabo to Set Up Marijuana Farm in Europe

27.04.18|Tofi Stoler
To carry out the plan, Kanabo is partnering with San Francisco-Based Cannabis Extract Manufacturer Constance Therapeutics
עלה קנאביס

Israeli Pharmacies To Begin Selling Medical Marijuana Products

09.04.18|Sefi Krupsky
On April 20, selected Israeli pharmacies will begin selling prescription cannabis products as part of a pilot program for the regulation of medical marijuana sales in Israel
הפגנה מפגינים פיטורים טבע אשדוד

Teva Executive Calls Company’s Fourth Quarter “Fairly Good”

11.02.18|Dror Reich
Following the publication of the company's reports, S&P Global downgraded Teva’s corporate credit rating to junk bonds
default image

Censa Pharmaceuticals Signs Joint Development Agreement with Biotech Company Retrophin

07.01.18|Lilach Baumer
Censa, a company developing treatments for orphan metabolic diseases, is a portfolio company of Israel-based Arkin Bio Ventures
Previous ArticlesMore Articles